Turmeric
Curcuma longa
Turmeric is a flowering plant, and its rhizome is commonly used as a spice in cooking. It is known for its vibrant yellow color and has been used in traditional medicine for centuries. The primary active compound in turmeric is curcumin, which has potent anti-inflammatory and antioxidant properties.
Why We Use it
Turmeric is a key ingredient in AlphaCleanse due to its powerful anti-inflammatory and liver-supportive benefits. It helps reduce liver inflammation, promotes bile production, and supports overall liver function. The addition of BioPerine (black pepper extract) enhances the bioavailability of curcumin, making it more effective.
Key Benefits
- Supports overall liver function*
- Promotes bile production*
- Enhanced absorption with BioPerine*
Turmeric has been used for over 4,000 years in Ayurvedic medicine to treat a variety of health conditions.
Science-Backed Evidence
| A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. 2019. | Department of Chemistry, Sharif University of Technology, Iran | |
| Curcumin: A Review of Its’ Effects on Human Health. 2017. | Department of Nutrition, Central Michigan University, USA | |
| The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial. 2019. | Department of Clinical Nutrition and Dietetics, Shahid Beheshti University of Medical Sciences, Iran | |
| Curcumin as adjuvant treatment in patients with non-alcoholic fatty liver (NAFLD) disease: A systematic review and meta-analysis. 2022. | Department of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia, Malaysia. | |
| Protective Effects of Curcumin Against Alcoholic Fatty Liver. 2023. | Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Iran | |
| Curcumin and Piperine Combination for the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled Trial. 2021. | Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran |
Ready to Feel the Difference?
Now that you’ve learned about the power of these ingredients, it’s time to experience the benefits for yourself.
Try Our Blends